Final results of first line treatment with 5-fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (L-OHP) in advanced colorectal cancer (ACC): A multicenter phase II study.

被引：0
|
作者：
Souglakos, J [1 ]
Kouroussis, C [1 ]
Ziras, N [1 ]
Malamos, N [1 ]
Potamianou, A [1 ]
Mavroudis, D [1 ]
Kakolyris, S [1 ]
Androulakis, N [1 ]
Vardakis, N [1 ]
Georgoulias, V [1 ]
机构：
[1] Greek Cooperat Grp GI Tumors, Heraklion, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
215P
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Fujimoto, Takashi
    Umehara, Arihiro
    Otani, Taisuke
    Matsumoto, Atsuo
    Osawa, Gakuji
    Shiozawa, Shunichi
    Katsube, Takao
    Naritaka, Yoshihiko
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2007, 27 (3B) : 1641 - 1644
  • [42] A multicenter phase Ib/ II study of liposomalirinotecan, 5-fluorouracil (5-FU), and leucovorin (LV) with nivolumab as second-line therapy for patients with advanced biliary tract cancer (BilT-03)
    Sahai, Vaibhav
    Griffith, Kent A.
    Lin, Bruce Shih-Li
    Soares, Heloisa P.
    Chandana, Sreenivasa R.
    Crysler, Oxana V.
    Enzler, Thomas
    Zalupski, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [43] Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study
    Kouroussis, C
    Souglakos, J
    Kakolyris, S
    Mavroudis, D
    Malamos, N
    Kalbakis, K
    Androulakis, N
    Agelaki, A
    Vardakis, N
    Samonis, G
    Georgoulias, V
    ONCOLOGY, 2001, 61 (01) : 36 - 41
  • [44] First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule
    Masi, G
    Allegrini, G
    Cupini, S
    Marcucci, L
    Cerri, E
    Brunetti, I
    Fontana, E
    Ricci, S
    Andreuccetti, M
    Falcone, A
    ANNALS OF ONCOLOGY, 2004, 15 (12) : 1766 - 1772
  • [45] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
    Yang, TS
    Chen, JS
    Tang, RP
    Chiang, JM
    Hsieh, PS
    Yeh, CY
    Changchien, CR
    CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
  • [46] Phase II study of irinotecan and high dose infusional 5-fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer.
    Leonard, P
    Ledermann, J
    James, R
    Hochhauser, D
    Seymour, M
    ANNALS OF ONCOLOGY, 2000, 11 : 44 - 45
  • [47] A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor receptor (EGFR). Preliminary results
    Hoehler, Thomas
    Dittrich, Christian
    Lordick, Florian
    Seufferlein, Thomas
    Riemann, Juergen F.
    Woell, Ewald
    Herrmann, Thomas
    Olchowka, Klaudia
    Kisker, Oliver
    Schmoll, Hans-Joachim
    ANNALS OF ONCOLOGY, 2004, 15 : 69 - 70
  • [48] A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
    Oliver F Bathe
    Scott Ernst
    Francis R Sutherland
    Elijah Dixon
    Charles Butts
    David Bigam
    David Holland
    Geoffrey A Porter
    Jennifer Koppel
    Scot Dowden
    BMC Cancer, 9
  • [49] TIMED-FLAT-INFUSION (TFI) OF 5-FLUOROURACIL (5-FU) PLUS WEEKLY ALTERNATING IRINOTECAN (CPT-11) AND OXALIPLATIN (L-OHP) IN ADVANCED COLORECTAL CANCER: PRELIMINARY RESULTS OF A DOSE-FINDING STUDY
    Morelli, M. F.
    Ricevuto, E.
    Calista, F.
    Gugliemi, F.
    Cannita, K.
    Rispoli, A. I.
    Santomaggio, A.
    Porzio, G.
    Lanfiuti, P.
    Mancini, M.
    Marchetti, P.
    Ficorella, C.
    ANNALS OF ONCOLOGY, 2004, 15 : 64 - 64
  • [50] PHASE II STUDY OF OXALIPLATIN COMBINED WITH LEUCOVORIN AND 5-FLUOROURACIL AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Lim, J. Y.
    Cho, J. Y.
    Jeung, H.
    Kim, S. H.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 183 - 184
12345